Seoul, South Korea

Sung Hwan Moon

USPTO Granted Patents = 2 

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sung Hwan Moon

Introduction

Sung Hwan Moon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the fields of cardiology and automotive technology. With a total of 2 patents, his work reflects a commitment to advancing medical and vehicular technologies.

Latest Patents

One of his latest patents is a method for producing cardiomyocytes from human or mouse embryonic stem cells in a medium consisting of a serum-free medium and N2 supplement. This invention relates to a method for producing embryonic stem cell-derived cardiomyocytes, which can be used to create cellular therapeutic agents for treating cardiac diseases. The method allows for the easy purification of differentiated cardiomyocytes from embryonic stem cells, which can then be utilized in the development of therapeutic agents for cardiac conditions.

Another significant patent involves a control method for a terminal mounted in a vehicle. This method includes receiving vehicle information messages, extracting vehicle data, generating a data package, and transmitting it to a data center. This innovation enhances the efficiency of data management in automotive systems.

Career Highlights

Sung Hwan Moon has worked with several prominent companies, including Chabio & Diostech Co., Ltd and Hyundai Motor Company. His experience in these organizations has contributed to his expertise in both medical and automotive technologies.

Collaborations

He has collaborated with various professionals in his field, including Hyung Min Chung, to further his research and development efforts.

Conclusion

Sung Hwan Moon's innovative work in producing cardiomyocytes and improving vehicle data management showcases his significant contributions to technology and medicine. His patents reflect a dedication to enhancing therapeutic options for cardiac diseases and advancing automotive technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…